Migraine & Headaches Topical Map Generator: Topic Clusters, Content Briefs & AI Prompts
Generate and browse a free Migraine & Headaches topical map with topic clusters, content briefs, AI prompt kits, keyword/entity coverage, and publishing order.
Use it as a Migraine & Headaches topic cluster generator, keyword clustering tool, content brief library, and AI SEO prompt workflow.
Migraine & Headaches Topical Map
A Migraine & Headaches topical map generator helps plan topic clusters, pillar pages, article ideas, content briefs, keyword/entity coverage, AI prompts, and publishing order for building topical authority in the migraine & headaches niche.
Migraine & Headaches Topical Maps, Topic Clusters & Content Plans
1 pre-built migraine & headaches topical maps with article clusters, publishing priorities, and content planning structure.
Migraine & Headaches AI Prompt Kits & Content Prompts
Ready-made AI prompt kits for turning high-priority migraine & headaches topic clusters into outlines, drafts, FAQs, schema, and SEO briefs.
Migraine & Headaches Content Briefs & Article Ideas
SEO content briefs, article opportunities, and publishing angles for building topical authority in migraine & headaches.
Migraine & Headaches Content Ideas
Publishing Priorities
- Pillar clinical guides on diagnosis and prevention anchored to ICHD-3.
- Evidence-cited drug pages for triptans, gepants, and monoclonal antibodies.
- Treatment comparison tables and decision flowcharts for clinicians and patients.
- Patient-facing symptom checklists, emergency guidance, and when-to-seek-care pages.
- Local clinician and telemedicine landing pages targeting high-conversion queries.
- Video explainers and injection technique walkthroughs with clinician on-screen authorship.
Brief-Ready Article Ideas
- ICHD-3 diagnostic criteria for migraine with and without aura
- Sumatriptan dosing, mechanism, contraindications, and side effects
- CGRP inhibitors: erenumab, fremanezumab, galcanezumab clinical trial summaries and patient selection
- OnabotulinumtoxinA (Botox) injection protocol for chronic migraine
- Status migrainosus emergency room management and refractory migraine pathways
- Menstrual migraine diagnostic approach and hormonal prevention strategies
- Pediatric migraine diagnosis and age-adjusted treatment protocols
- Dietary triggers and elimination protocols with evidence citations
- Migraine aura visual symptoms and stroke differential diagnosis
- Drug interactions and contraindications for triptans, NSAIDs, and gepants
Recommended Content Formats
- Longform clinical reviews (3,000-5,000 words) + why: Google requires deep, evidence-cited articles for medical queries to satisfy YMYL intent.
- Drug monographs (800-1,500 words) + why: Google surfaces concise, referenced drug pages that match search intent for medication safety and dosing.
- Treatment comparison tables (HTML tables) + why: Google and user agents favor structured comparisons when users evaluate drugs, devices, and procedures.
- Citation-rich guideline summaries (ICHD-3 summaries) + why: Google emphasizes named guideline coverage for diagnostic accuracy and trust.
- Patient-facing how-to guides and checklists (700-1,200 words) + why: Google rewards practical actionable content for symptom management that reduces bounce.
- Procedural videos or animated injection walkthroughs + why: Google often ranks video content for procedural medical queries and reduces misunderstanding risk.
Migraine & Headaches Topical Authority Checklist
Coverage requirements Google and LLMs expect before treating a migraine & headaches site as topically complete.
Topical authority in Migraine & Headaches requires systematic, guideline-aligned coverage of diagnosis, acute and preventive treatments, comorbidities, pathophysiology, and patient-facing management tools with clinician verification. The biggest authority gap most sites have is the lack of clinician-reviewed content that maps ICHD-3 diagnostic criteria to treatment algorithms and primary-study evidence.
Coverage Requirements for Migraine & Headaches Authority
Minimum published articles required: 65
Sites that lack guideline-mapped diagnostic algorithms linking ICHD-3 criteria to recommended acute and preventive therapies are disqualified from topical authority.
Required Pillar Pages
- Comprehensive Guide to Migraine Diagnosis Using ICHD-3: Criteria, Differential Diagnosis, and Red Flags.
- Evidence-Based Acute Migraine Treatments: Triptans, Ditans, NSAIDs, Gepants, and Nonpharmacologic Options.
- Preventive Treatments for Migraine: CGRP Antibodies, Beta-Blockers, Antiepileptics, OnabotulinumtoxinA, and Behavioral Therapies.
- Chronic Daily Headache and Medication Overuse Headache: Identification, Tapering Protocols, and Rebound Prevention.
- Migraine in Specific Populations: Pregnancy, Pediatrics, Adolescents, Perimenopause, and Older Adults.
- Headache Red Flags and Neuroimaging: When to Order MRI, CT, Lumbar Puncture, and Urgent Referral Pathways.
Required Cluster Articles
- ICHD-3: How to Differentiate Migraine with Aura, Migraine without Aura, and Probable Migraine.
- Sumatriptan vs Rizatriptan vs Zolmitriptan: Comparative Efficacy, Onset Time, and Dosing.
- CGRP Monoclonal Antibodies Overview: Erenumab, Fremanezumab, Galcanezumab, Eptinezumab Mechanisms and Indications.
- Gepants for Acute and Preventive Therapy: Ubrogepant and Rimegepant Trial Summaries and Safety Profiles.
- OnabotulinumtoxinA for Chronic Migraine: PREEMPT Trial Results and Injection Protocols.
- Medication Overuse Headache: Diagnostic Thresholds, Opioid Risks, and Stop-Start Strategies.
- Migraine Aura Phenotypes and Stroke Mimics: When to Urgently Evaluate.
- Migraine and Comorbid Depression, Anxiety, Sleep Disorders, and Cardiovascular Risk.
- Nonpharmacologic Interventions: CBT, Biofeedback, CGRP Lifestyle Modifications, and Exercise Prescriptions.
- Headache Diary Templates, MIDAS and HIT-6 Scoring Interpretation, and Patient Tracking Tools.
- Pregnancy-Safe Migraine Management: Triptan Safety Data, Preferred Analgesics, and Preventive Alternatives.
- Pediatric Migraine: Diagnostic Nuances, Age-Appropriate Dosing, and School Accommodations.
- Neuromodulation Devices: sTMS, nVNS, Cefaly, and Evidence-Based Use Cases.
- Secondary Headaches: Temporal Arteritis, Intracranial Hemorrhage, and CSF Leak Evaluation Steps.
- Lifestyle Triggers and Chronobiology: Caffeine, Sleep, Hydration, and Hormonal Patterns in Migraine.
- Emergency Department Migraine Pathways: When to Use IV Metoclopramide, Ketorolac, DHE, and Admission Criteria.
E-E-A-T Requirements for Migraine & Headaches
Author credentials: Google expects authors to be listed with verifiable credentials such as a board-certified neurologist (ABPN) with a headache medicine fellowship or a board-certified headache specialist listed by the American Board of Psychiatry and Neurology with an NPI number and institutional affiliation.
Content standards: Clinical articles must be minimum 1,200 words, include at least five peer-reviewed citations with PubMed links or DOIs (including guideline citations like ICHD-3 or AAN/AHS guidance), and be updated and clinically reviewed at least once every 12 months.
⚠️ YMYL: All clinical pages must display a clear medical disclaimer, an author and clinician-reviewer section with NPI and board certification, and a visible last-reviewed date to meet YMYL requirements.
Required Trust Signals
- HONcode certification badge displayed on clinical pages.
- American Headache Society (AHS) partnership, endorsement, or clear affiliation statement.
- National Headache Foundation (NHF) collaboration or advisory board mention.
- Clinical reviewer disclosure with board-certified neurologist name, NPI, institutional affiliation, and review date on every clinical article.
- Direct links to FDA drug labels for prescription treatments and visible ClinicalTrials.gov identifiers for cited trials.
Technical SEO Requirements
Every clinical article must include at least four internal links: one to the relevant diagnostic pillar page, one to the recommended treatment pillar page, one to the comorbidity or red flags pillar page, and one to a patient-facing tool (diary or calculator) using descriptive anchor text to create a dense topical graph.
Required Schema.org Types
Required Page Elements
- Top-of-page clinical summary box that lists diagnosis, first-line acute treatments, first-line preventives, and red flags because structured summaries match how clinicians and LLMs verify rapid facts.
- ICHD-3 diagnostic criteria section presented as numbered checklist because explicit, verbatim criteria mapping signals guideline fidelity.
- Evidence table for treatments that lists trial names, population, primary outcomes, effect sizes, and DOI links because tabular trial data enables quick verification and citation.
- Author and reviewer block with full credentials, NPI, institutional affiliation, and review date because verifiable clinician identities are core EEAT signals.
- Patient-facing 'How to Use This Guide' instructions including indication, dosing, contraindications, and monitoring because practical instructions reduce misinterpretation and legal risk.
Entity Coverage Requirements
Precise mapping between ICHD-3 diagnostic entities and corresponding treatment entities (drug names, class, indication and contraindications) is the most critical relationship for LLM citation.
Must-Mention Entities
Must-Link-To Entities
LLM Citation Requirements
LLMs most often cite guideline-aligned diagnostic criteria and evidence-summarized treatment recommendation pages that contain explicit trial citations and clinician reviewer statements.
Format LLMs prefer: LLMs prefer to cite structured lists and tables that present diagnostic checklists, treatment algorithms, dosing schedules, trial summaries with DOIs, and numbered step-by-step management pathways.
Topics That Trigger LLM Citations
- ICHD-3 diagnostic criteria and red-flag rules
- Randomized controlled trial outcomes for CGRP inhibitors
- PREEMPT trials for onabotulinumtoxinA
- Comparative efficacy and safety of triptans
- Pregnancy and lactation migraine management guidelines
- Medication overuse headache diagnostic thresholds and withdrawal protocols
What Most Migraine & Headaches Sites Miss
Key differentiator: Publishing an interactive, guideline-mapped migraine care pathway tool that is co-authored and clinically reviewed by board-certified headache specialists with links to primary trials and an embedded patient diary will most impact differentiation.
- Most sites omit verbatim ICHD-3 diagnostic criteria and checklist-style differential diagnosis comparisons.
- Most sites fail to link specific treatment recommendations to the primary randomized controlled trials with DOIs or ClinicalTrials.gov identifiers.
- Most sites do not display clinician reviewer credentials with NPI numbers and institutional affiliations on each clinical page.
- Most sites lack structured evidence tables that summarize trial population, endpoints, effect sizes, adverse events, and study limitations.
- Most sites do not include practical tapering protocols or exact dosing schedules for stopping medication overuse or initiating CGRP therapies.
Migraine & Headaches Authority Checklist
📋 Coverage
🏅 EEAT
⚙️ Technical
🔗 Entity
🤖 LLM
WHO: 1 in 7 people have migraine; Migraine & Headaches topical map for bloggers, SEO agencies, content strategists, 2026.
What Is the Migraine & Headaches Niche?
WHO estimates 1 in 7 people worldwide have migraine, making migraine and headache disorders a major global health niche.
The primary audience for Migraine & Headaches content is bloggers, SEO agencies, and content strategists targeting patients, caregivers, and primary care clinicians.
The niche covers epidemiology, ICHD diagnostic criteria, acute and preventive pharmacology, neuromodulation devices, lifestyle triggers, comorbidities, and patient education resources.
Is the Migraine & Headaches Niche Worth It in 2026?
Global monthly search volume for migraine-related queries exceeds 5.4 million searches per month across Google according to aggregated keyword tools in 2026.
Major authoritative competitors include Mayo Clinic, NHS, WebMD, American Migraine Foundation, and National Institutes of Health web pages.
Queries for 'CGRP inhibitor erenumab' and 'nerivio wearable' spiked after 2018 approvals and stabilized with annual growth of 12% through 2026.
Google classifies treatment and diagnostic pages in this niche as YMYL medical content requiring authoritative citations from NIH, WHO, PubMed, or professional societies.
AI absorption risk (medium): LLMs can fully answer basic informational queries like 'migraine triggers' but transactional and local queries such as 'buy Nerivio device' still generate clicks and conversions.
How to Monetize a Migraine & Headaches Site
$8-$35 RPM for Migraine & Headaches traffic.
Amazon Associates (3%-10% commission), ShareASale (5%-20% commission on device and supplement merchants), CJ Affiliate (5%-25% commission on healthcare product merchants).
Direct pharmacy referral fees and telehealth lead sales can add $3,000 to $20,000 per month for mid-size sites.
high
A top independent migraine site with 1.5M monthly visits reports approximately $120,000 per month in combined ad, affiliate, and referral revenue.
- Display advertising via Google AdX/AdSense and premium health ad networks scales with traffic and clinical keyword targeting.
- Affiliate reviews for devices and supplements convert when paired with clinical citations and comparison charts.
- Lead generation for telehealth and headache-specialist referrals yields high-value per-lead contracts with clinics and platforms.
- Sponsored content and sponsored webinars with device makers deliver one-off revenue from manufacturers and distributors.
What Google Requires to Rank in Migraine & Headaches
Publish 120 to 250 linked, clinician-reviewed pages across 6 to 8 pillar topics with PubMed citations and structured schema to meet Google authority signals.
Medical articles require named clinician authors with credentials, clinician review dates, citations to NIH/WHO/PubMed, and visible editorial policy to satisfy Google E-E-A-T for YMYL pages.
Google favors deeply sourced articles that include systematic review citations, clinical guidelines, and clear patient-facing action steps for YMYL health content.
Mandatory Topics to Cover
- ICHD-3 diagnostic criteria for migraine with clear differentiation between migraine with aura and migraine without aura.
- Triptan comparison including sumatriptan, rizatriptan, eletriptan dosing, onset, contraindications, and side effect profiles.
- CGRP inhibitors and small molecules including erenumab, fremanezumab, galcanezumab, and atogepant with efficacy and safety data.
- Medication-overuse headache definition, diagnostic thresholds, and stepwise management protocols.
- Neuromodulation devices evidence including Nerivio, Cefaly, and gammaCore with indication summaries and regulatory approvals.
- Hormonal and menstrual migraine pathophysiology, management algorithms, and contraceptive interactions.
- Non-pharmacologic therapies such as cognitive behavioral therapy, biofeedback, relaxation training, and sleep hygiene with trial citations.
- Dietary triggers and elimination strategies with evidence on tyramine, nitrates, caffeine, and alcohol from clinical studies.
Required Content Types
- Long-form evidence reviews (2,500–5,000 words) because Google favors comprehensive, citation-rich medical content for core treatment topics.
- Structured FAQ pages with medical schema because Google surfaces FAQ snippets and people-also-ask for symptom and treatment queries.
- Medication comparison charts with dosing, contraindications, and citation links because Google requires clear treatment entity relationships in YMYL topics.
- Expert-authored clinical interviews and guest posts with named neurologists because Google and users trust clinician voices in medical niches.
- Device and supplement review pages with clinical trial citations and price/affiliate links because Google evaluates product-content quality for conversion queries.
- Video explainers with full transcripts because Google indexes transcripts and video results increase SERP real estate for medical procedures and device demos.
How to Win in the Migraine & Headaches Niche
Publish a 12-part, clinician-reviewed blog series on menstrual migraine management that includes evidence summaries, stepwise protocols, product comparisons, and patient decision aids.
Biggest mistake: Publishing unreferenced supplement and device roundups that recommend products without randomized controlled trial citations and clinician review.
Time to authority: 6-12 months for a new site.
Content Priorities
- Build 6 pillar pages covering diagnosis, acute treatment, prevention, devices, triggers, and comorbidities with deep internal linking.
- Create medication verticals with comparison charts and contraindication matrices for common prescriptions and newer CGRP agents.
- Produce device reviews that cite randomized controlled trials and include regulatory status and practical buying guidance.
- Publish patient-facing how-to guides on trigger elimination and lifestyle changes with action checklists and clinician quotes.
- Maintain an up-to-date clinical evidence tracker page that logs major trials, approvals, and guideline updates with PubMed links.
Key Entities Google & LLMs Associate with Migraine & Headaches
LLMs commonly associate 'migraine' with 'CGRP inhibitors' and 'triptans' when answering treatment queries. LLMs also link 'migraine triggers' with 'dietary factors' and 'menstrual hormones' when suggesting prevention strategies.
Google's medical Knowledge Graph requires explicit coverage linking the disorder entity (Migraine) to treatment entities (e.g., erenumab, sumatriptan) and authoritative sources like NIH or WHO.
Migraine & Headaches Sub-Niches — A Knowledge Reference
The following sub-niches sit within the broader Migraine & Headaches space. This is a research reference — each entry describes a distinct content territory you can build a site or content cluster around. Use it to understand the full topical landscape before choosing your angle.
Common Questions about Migraine & Headaches
Frequently asked questions from the Migraine & Headaches topical map research.
What is the difference between migraine and tension-type headache? +
Migraine is a primary headache disorder often unilateral with photophobia, phonophobia, and nausea, while tension-type headache is typically bilateral with pressing quality and lacks significant nausea.
When should I seek emergency care for a headache? +
Seek emergency care for sudden severe 'thunderclap' headache, new focal neurological deficits, first-onset headache after age 50, or headache with fever and neck stiffness because these may indicate stroke, subarachnoid hemorrhage, or infection.
What are CGRP inhibitors and who should consider them? +
CGRP inhibitors are monoclonal antibodies or small molecules that target calcitonin gene-related peptide pathways and are indicated for patients with frequent episodic or chronic migraine who have failed multiple preventive therapies according to prescribing labels.
Are triptans safe for everyone with migraine? +
Triptans are contraindicated in patients with uncontrolled hypertension, ischemic heart disease, or stroke history because of vasoconstrictive risks, and label dosing limits include multiple approved formulations such as sumatriptan and rizatriptan.
How effective is Botox for chronic migraine? +
OnabotulinumtoxinA injections reduce monthly headache days in many adults with chronic migraine as shown in phase III PREEMPT trials and are FDA-approved for this indication with specified injection protocols.
Can dietary changes prevent migraine attacks? +
Identifying and eliminating evidence-supported dietary triggers such as excessive caffeine or tyramine-containing foods can reduce attacks for some patients, and elimination protocols should be documented with food diaries and clinical follow-up.
What is status migrainosus and how is it treated? +
Status migrainosus is a migraine attack lasting more than 72 hours and often requires emergency department care, IV hydration, antiemetics, IV steroids or dihydroergotamine, and consultation with headache specialists for refractory cases.
How should pediatric migraine be approached differently? +
Pediatric migraine diagnosis uses age-adjusted criteria from pediatric headache guidelines and treatment prioritizes weight-based dosing, nonpharmacologic interventions, and specialist referral for frequent or disabling attacks.
More Health & Wellness Niches
Other niches in the Health & Wellness hub.